Cochrane for Clinicians: Effectiveness and Safety of Celecoxib for the Treatment of Rheumatoid Arthritis

Kristian Sanchack, Sajeewane Seales, Paul Seales

Research output: Contribution to journalReview articlepeer-review

Abstract

Evidence-Based Answer Compared with placebo, celecoxib improves pain (number needed to treat [NNT]= 4) and clinical symptoms (NNT= 7), but it has no effect on physical function in patients with RA. 1 (Strength of Recommendation [SOR]= A, based on moderate-quality evidence.) Compared with traditional nonsteroidal anti-inflammatory drugs (NSAIDs), celecoxib is no better at improving pain or physical function in patients with RA. Celecoxib causes fewer gastroduodenal ulcers (at least 3 mm in size) than traditional NSAIDs (number needed to harm [NNH] with traditional NSAIDs as opposed to celecoxib= 9). 1 (SOR= A, based on moderate-quality evidence.) Practice Pointers RA is a common type of inflammatory arthritis.[...] fewer patients discontinued celecoxib therapy (7%) than traditional NSAID therapy (14%; absolute change= 7%; 95% CI, 4% to 9%; NNH= 14 [95% CI, 11 to 23]).
Original languageAmerican English
Pages (from-to)573
JournalAmerican Family Physician
Volume97
Issue number9
StatePublished - 1 May 2018

Fingerprint

Dive into the research topics of 'Cochrane for Clinicians: Effectiveness and Safety of Celecoxib for the Treatment of Rheumatoid Arthritis'. Together they form a unique fingerprint.

Cite this